Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Kazuhiko Hanada"'
Autor:
Fumiya Watanabe, Yasuhiko Matsumoto, Takashi Sugita, Yuta Morishige, Satoshi Mitarai, Yoshihiko Hoshino, Kazuhiko Hanada
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract Pulmonary Mycobacterium avium-intracellulare complex (MAC) disease is a typical non-tuberculous mycobacterial infection. The incidence of pulmonary MAC is increasing worldwide. This study aimed to clarify the pharmacokinetic parameters of an
Externí odkaz:
https://doaj.org/article/96ec4dcf4dea49dc92d258f1d887dedb
Autor:
Masao Kobayakawa, Tohru Shiga, Kazuhiro Takahashi, Shigeyasu Sugawara, Kaori Nomura, Kazuhiko Hanada, Naoki Ishizuka, Hiroshi Ito
Publikováno v:
PLoS ONE, Vol 19, Iss 5, p e0303623 (2024)
BackgroundPheochromocytoma, or paraganglioma (PPGL), is a tumor that arises from catecholamine-producing chromaffin cells of the adrenal medulla or paraganglion. Systemic therapy, such as the combination of cyclophosphamide, vincristine, and dacarbaz
Externí odkaz:
https://doaj.org/article/bea868d35c494fdab479d0220915f1a5
Autor:
Hiroshi Sasano, Kazuhiko Hanada
Publikováno v:
Antibiotics, Vol 12, Iss 11, p 1577 (2023)
Purpose: Enterococcal bacteremia is associated with high mortality and long-term hospitalization. Here, we aimed to investigate the clinical outcomes and evaluate the risk factors for mortality in adult patients treated with vancomycin (VCM) for vanc
Externí odkaz:
https://doaj.org/article/9d746c83dbe94ec48901e6cbc02c0c71
Autor:
Chenxue Mao, Juan Chen, Ting Zou, Yuankang Zhou, Junyan Liu, Xi Li, Xiangping Li, Min Li, Pinhua Pan, Wei Zhuo, Yang Gao, Shuo Hu, Desheng Xiao, Lin Wu, Zhan Wang, Heng Xu, Wen Yang, Yingjie Xu, Haihua Xiao, Kazuhiko Hanada, Wei Zhang, Honghao Zhou, Jiye Yin, Zhaoqian Liu
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 12, Iss 3, Pp 1514-1522 (2022)
To explore the pharmacogenomic markers that affect the platinum-based chemotherapy response in non-small-cell lung carcinoma (NSCLC), we performed a two-cohort of genome-wide association studies (GWAS), including 34 for WES-based and 433 for microarr
Externí odkaz:
https://doaj.org/article/b24818bebe05422f9bcb071688fec272
Autor:
Kaho Miura, Yoshiyuki Sano, Seiji Niho, Kenji Kawasumi, Nobuo Mochizuki, Kiyotaka Yoh, Shingo Matsumoto, Yoshitaka Zenke, Takaya Ikeda, Kaname Nosaki, Keisuke Kirita, Hibiki Udagawa, Koichi Goto, Toshikatsu Kawasaki, Kazuhiko Hanada
Publikováno v:
Thoracic Cancer, Vol 12, Iss 13, Pp 1983-1994 (2021)
Abstract Background It has recently been suggested that concomitant medication may affect the clinical outcome of patients treated with immune checkpoint inhibitors (ICIs). However, only a few studies on the impact of concomitant medication on immune
Externí odkaz:
https://doaj.org/article/c2b2b23ff3964b8ba27171c6dc3821fb
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background While epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) exert a breakthrough effect, the incidence of skin disorders as a side effect has significantly reduced patients’ quality of life. This study aimed
Externí odkaz:
https://doaj.org/article/4d1dc47754144f5cab59742d5201f976
Autor:
Toshinori Hirai, Chihiro Shiraishi, Sumire Nakai, Miu Ushiro, Kazuhiko Hanada, Takuya Iwamoto
Publikováno v:
Basic & Clinical Pharmacology & Toxicology. 131:380-391
Since trimethoprim (TMP) dose-dependently inhibits the excretion of potassium, a population kinetic-pharmacodynamic analysis was performed to establish an adequate dosing schedule and characterize factors of hyperkalaemia. Dataset was constructed usi
Autor:
Tomoko O. Morita, Kazuhiko Hanada
Publikováno v:
Cancer Chemotherapy and Pharmacology. 90:315-323
Autor:
Toshinori Hirai, Hidefumi Kasai, Masahiro Takahashi, Satomi Uchida, Naoko Akai, Kazuhiko Hanada, Toshimasa Itoh, Takuya Iwamoto
Publikováno v:
Biological and Pharmaceutical Bulletin. 45:948-954
Autor:
Xi Li, Hong-Hao Zhou, Ji-Ye Yin, Heng Xu, Yingjie Xu, Chen-Xue Mao, Jun-Yan Liu, Haihua Xiao, Yuan-Kang Zhou, Zhan Wang, Min Li, Wei Zhuo, Desheng Xiao, Lin Wu, Wen Yang, Pinhua Pan, Xiang-Ping Li, Yang Gao, Juan Chen, Shuo Hu, Wei Zhang, Kazuhiko Hanada, Ting Zou, Zhao-Qian Liu
Publikováno v:
Acta Pharmaceutica Sinica B. 12:1514-1522
To explore the pharmacogenomic markers that affect the platinum-based chemotherapy response in non-small-cell lung carcinoma (NSCLC), we performed a two-cohort of genome-wide association studies (GWAS), including 34 for WES-based and 433 for microarr